Fabio Morandi
Laboratory of Oncology
G. Gaslini Scientific Institute
Largo G. Gaslini 5
16148 Genova
Italy
[email]@ospedale-gaslini.ge.it
Name/email consistency: high
- HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Prigione, I., Penco, F., Martini, A., Gattorno, M., Pistoia, V., Morandi, F. Rheumatology. (Oxford) (2011)
- A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. Morandi, F., Ferretti, E., Bocca, P., Prigione, I., Raffaghello, L., Pistoia, V. PLoS. ONE (2010)
- Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Morandi, F., Raffaghello, L., Bianchi, G., Meloni, F., Salis, A., Millo, E., Ferrone, S., Barnaba, V., Pistoia, V. Stem. Cells (2008)
- Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Morandi, F., Levreri, I., Bocca, P., Galleni, B., Raffaghello, L., Ferrone, S., Prigione, I., Pistoia, V. Cancer Res. (2007)
- Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications. Morandi, F., Chiesa, S., Bocca, P., Millo, E., Salis, A., Solari, M., Pistoia, V., Prigione, I. Neoplasia (2006)
